Furthermore, pharmacological suppression of BCL3 systemically in mice inhibited both the experimental metastatic seeding of human triple negative breast cancer (MDA-MB-231) cells and the spontaneous metastasis of syngeneic mammary 4 T1.2 cells in vivo [111]. This evidence concerns the gene BCL3 and triple-negative breast carcinoma.